EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Deciphering Benign and Malignant Perineuriomas: A Comparative Epigenomic and Genomic Study With Hybrid and Malignant Peripheral Nerve Tumors

Ashley Patton, Carina A Dehner, Travis Hattery, Mark J Chen, Sheila Shurtleff, Elizabeth M Azzato, Scott E Kilpatrick, John R Goldblum, Brian R Rubin, Steven D Billings, Karen J Fritchie, John S A Chrisinger und 2 weitere

Modern Pathology · 2026-11 · 101114

DOI: 10.1016/j.modpat.2026.101114 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Pathology, 2026-11. Verfasst von Ashley Patton und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The Ohio State University Wexner Medical Center, Columbus, Ohio. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: US Department of War.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Perineuriomas are uncommon benign peripheral nerve sheath tumors composed of perineurial cells. Conventional perineurioma and sclerosing variants overlap histologically with several soft tissue tumors, including low-grade fibromyxoid sarcoma, dermatofibrosarcoma protuberans, and sclerosing epithelioid fibrosarcoma. EMA and GLUT1 immunohistochemistry lack specificity, and recurrent genetic alterations have not been consistently identified. Malignant perineuriomas are exceptionally rare, may mimic YAP1::KMT2A-rearranged and TRAF7-mutant sarcomas, and remain poorly defined relative to malignant peripheral nerve sheath tumors (MPNST). We investigated whether DNA methylation profiling could refine classification and clarify epigenetic relationships with potential mimics. DESIGN: A multi-institutional cohort included conventional perineurioma (23), sclerosing perineurioma (9), pseudolipoblastic perineurioma (1), hybrid schwannoma-perineurioma (12), and malignant perineurioma (18). DNA methylation profiling was performed using the Illumina Infinium EPICv2 array. Comparative genomic profiling was also performed in 7 malignant perineuriomas and 16 MPNSTs. RESULTS: Conventional and sclerosing perineuriomas displayed a unified, distinct DNA methylation profile relative to mesenchymal mimics. Twenty-five percent of benign perineuriomas harbored mutually exclusive NF1 or NF2 deletions. Hybrid schwannoma-perineuriomas overlapped epigenetically with neurofibromas, whereas perineuriomas demonstrated hypomethylation of genes involved in cell junction/cell-matrix interactions and hypermethylation of genes involved in nervous system development. Patients with malignant perineurioma were significantly older and had larger tumors than those with benign variants or hybrid schwannoma-perineurioma. At median 21-month follow-up, 3 had local recurrence, 1 presented with multiple pleural masses, and 2 died of progressive disease. Most malignant perineuriomas (10/18) did not cluster with benign perineuriomas or MPNST but instead showed closer epigenetic similarity to undifferentiated sarcoma. They also exhibited significantly greater genome-wide copy number variation and heterogeneous genomic profiles, including loss-of-function PTPRD, TP53, ATM, and RB1 alterations. CONCLUSION: Perineuriomas are epigenetically distinct. Hybrid schwannoma-perineuriomas are epigenetically related to neurofibromas. Histologically diagnosed malignant perineuriomas may represent biologically heterogeneous high-grade sarcomas rather than a distinct perineurial neoplasm.

Schlagwörter

Stichwörter der Autor:innen

Perineuriomahybrid peripheral nerve sheath tumormethylation profiling

Autor:innen und Institutionen

  • Department of Pathology, The Ohio State University Wexner Medical Center, Columbus, Ohio.
  • Department of Pathology, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Department of Pathology and Laboratory Medicine, Cleveland Clinic, Cleveland, Ohio.
  • Department of Pathology and Immunology, Division of Anatomic and Molecular Pathology, Washington University School of Medicine, St. Louis, Missouri.
  • Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden.
  • Department of Pathology and Laboratory Medicine, Cleveland Clinic, Cleveland, Ohio. Electronic address: dermawj@ccf.org.

Förderung

  • US Department of War

Zitieren

APA

Patton, A., Dehner, C. A., Hattery, T., Chen, M. J., Shurtleff, S., Azzato, E. M., Kilpatrick, S. E., Goldblum, J. R., Rubin, B. R., Billings, S. D., Fritchie, K. J., Chrisinger, J. S. A., Hanglund de Flon, F., & Dermawan, J. K. (2026). Deciphering Benign and Malignant Perineuriomas: A Comparative Epigenomic and Genomic Study With Hybrid and Malignant Peripheral Nerve Tumors. Modern Pathology, 101114. https://doi.org/10.1016/j.modpat.2026.101114

Vancouver

Patton A, Dehner CA, Hattery T, Chen MJ, Shurtleff S, Azzato EM, et al. Deciphering Benign and Malignant Perineuriomas: A Comparative Epigenomic and Genomic Study With Hybrid and Malignant Peripheral Nerve Tumors. Modern Pathology. 2026:101114. doi:10.1016/j.modpat.2026.101114

BibTeX
@article{Patton2026,
  author = {Patton, Ashley and Dehner, Carina A and Hattery, Travis and Chen, Mark J and Shurtleff, Sheila and Azzato, Elizabeth M and Kilpatrick, Scott E and Goldblum, John R and Rubin, Brian R and Billings, Steven D and Fritchie, Karen J and Chrisinger, John S A and Hanglund de Flon, Felix and Dermawan, Josephine K},
  title = {Deciphering Benign and Malignant Perineuriomas: A Comparative Epigenomic and Genomic Study With Hybrid and Malignant Peripheral Nerve Tumors},
  journal = {Modern Pathology},
  year = {2026},
  pages = {101114},
  doi = {10.1016/j.modpat.2026.101114}
}
Kostenlos starten →